Patents by Inventor Hang KE

Hang KE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12195545
    Abstract: Provided in the present invention are an anti-OX40 monoclonal antibody or an antigen-binding fragment thereof, and a corresponding isolated polynucleotide, expression vector, recombinant cell, pharmaceutical composition, and application thereof. The present antibody can be used for the treatment of cancer or autoimmune disease.
    Type: Grant
    Filed: December 25, 2018
    Date of Patent: January 14, 2025
    Assignee: HANX BIOPHARMACEUTICS, INC
    Inventors: Ying Huang, Faming Zhang, Hang Ke
  • Publication number: 20220017632
    Abstract: Provided in the present invention are an anti-OX40 monoclonal antibody or an antigen-binding fragment thereof, and a corresponding isolated polynucleotide, expression vector, recombinant cell, pharmaceutical composition, and application thereof. The present antibody can be used for the treatment of cancer or autoimmune disease.
    Type: Application
    Filed: December 25, 2018
    Publication date: January 20, 2022
    Inventors: Ying HUANG, Faming ZHANG, Hang KE